Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. | 4,574,554 | reported | 12 Nov 2025 | tx 13+11,953,674−7,014,550 |
| Design Therapeutics, Inc. | 750,000 | reported | 02 Jan 2026 | tx 12+5,519,923−171,025 |
| TRANZYME INC | 20,000 | reported | 30 Aug 2013 | tx 1+20,000 |
| Synthorx, Inc. | 0 | reported | 23 Jan 2020 | tx 3+10,223−72,635 |
| Auspex Pharmaceuticals, Inc. | 0 | reported | 05 May 2015 | tx 7+308,333−1,418,171 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Design Therapeutics, Inc. | 750,000 | 0.00 USD | deriv |
| 09 Dec 2025 | GRANT_AWARD | Design Therapeutics, Inc. | 525,000 | 0.00 USD | deriv |
| 09 Dec 2025 | GRANT_AWARD | Design Therapeutics, Inc. | 525,000 | 0.00 USD | deriv |
| 12 Nov 2025 | GIFT | ARS Pharmaceuticals, Inc. | 100,000 | 0.00 USD | |
| 12 Nov 2025 | GIFT | ARS Pharmaceuticals, Inc. | 250,000 | 0.00 USD | |
| 25 Jun 2025 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Design Therapeutics, Inc. | 600,000 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |
| 13 Jun 2024 | GIFT | ARS Pharmaceuticals, Inc. | 1,132,900 | 0.00 USD | |
| 13 Jun 2024 | GIFT | ARS Pharmaceuticals, Inc. | 200,000 | 0.00 USD | |
| 07 Jun 2024 | GIFT | ARS Pharmaceuticals, Inc. | 1,332,950 | 0.00 USD | |
| 04 Jun 2024 | OTHER | ARS Pharmaceuticals, Inc. | 2,665,800 | — | |
| 04 Jun 2024 | GIFT | ARS Pharmaceuticals, Inc. | 1,332,900 | 0.00 USD | |
| 04 Jun 2024 | GIFT | ARS Pharmaceuticals, Inc. | 1,332,900 | 0.00 USD | |
| 01 Sept 2023 | GRANT_AWARD | Design Therapeutics, Inc. | 1,050,000 | 0.00 USD | deriv |
| 01 Sept 2023 | GRANT_AWARD | Design Therapeutics, Inc. | 525,000 | 0.00 USD | deriv |
| 01 Sept 2023 | GRANT_AWARD | Design Therapeutics, Inc. | 525,000 | 0.00 USD | deriv |
| 27 Jun 2023 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |
| 01 Feb 2023 | GRANT_AWARD | Design Therapeutics, Inc. | 415,000 | 0.00 USD | deriv |
| 08 Nov 2022 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 10,156,204 | — | |
| 08 Nov 2022 | GRANT_AWARD | ARS Pharmaceuticals, Inc. | 354,570 | — | deriv |
| 01 Feb 2022 | GRANT_AWARD | Design Therapeutics, Inc. | 475,000 | 0.00 USD | deriv |
| 30 Mar 2021 | CONVERSION | Design Therapeutics, Inc. | 104,923 | — | |
| 30 Mar 2021 | PURCHASE | Design Therapeutics, Inc. | 25,000 | 20.00 USD | first after silence |
| 30 Mar 2021 | CONVERSION | Design Therapeutics, Inc. | 171,025 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 30 Mar 2021.